Stay updated with breaking news from Current Problems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Compared with placebo, bempedoic acid therapy decreased the risk for major adverse cardiovascular events among patients at high cardiovascular risk, according to a new systematic review and meta-analysis. Bempedoic acid is approved for heterozygous familial hypercholesterolemia and atherosclerotic cardiovascular disease.
New research from the Smidt Heart Institute shows that heart attack patients who also had COVID-19 were three times more likely to die in the hospital
A study found a 26.9 percent increase in diagnostic imaging interpretation done by nurse practitioners and physician assistants between 2016 and 2020.
TUESDAY, June 13, 2023 (HealthDay News) -- Patients with COVID-19 and acute myocardial infarction (AMI) experienced higher rates of mortality and complications than patients without COVID-19, with racial disparities identified,
TUESDAY, June 13, 2023 (HealthDay News) -- Patients with COVID-19 and acute myocardial infarction (AMI) experienced higher rates of mortality and complications than patients without COVID-19, with racial disparities identified,